Dr. Jianqing Lin, MD

  • Rockingham, VA
  • Medical oncologist
NPI1285787267PAC ID3971658733
Medicare services, 2024
1,061
Medicare patients, 2024
342
Part D claims, 2024
1,242
Publications
34
Clinical trials
10
Practice address
2010 Health Campus Drive, Harrisonburg, VA 22801
Practice phone
Call (540) 689-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Sentara RMH Medical Center

Hospital · Harrisonburg, Virginia

See all 5 affiliations

Find Dr. Lin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Jianqing Lin is a medical oncologist in Rockingham, Virginia

Dr. Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health.

Dr. Lin's NPI, 1285787267, was assigned on January 21, 2007. Dr. Lin holds Virginia license 0101276780.

NPI and contact details
Medicare PAC ID
3971658733
NPI enumeration date
January 21, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(540) 689-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
66
Medical school graduation
1986

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Jianqing Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia

Dr. Lin's primary practice is Sentara RMH Medical Center, at 2010 Health Campus Drive, Harrisonburg, VA 22801 in Harrisonburg City. The practice phone is (540) 689-1000.

Source: Dmand AI Affiliation Data

Dr. Jianqing Lin is affiliated with 4 sites of care and 1 medical group

Dr. Lin's primary practice is Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health. Dr. Lin is also affiliated with University Medical Center. The medical group on file is Sentara RMH Medical Group. Dmand AI also links Dr. Lin to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Lin

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Jianqing Lin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sentara RMH Medical CenterAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Sentara Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Jianqing Lin is one of 99 medical oncologists in Virginia

Medical oncology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Lin's licenses on file in 4 states: Virginia, District of Columbia, Maryland and Pennsylvania.

Specialties and state licenses

  • Medical oncology, VirginiaPrimaryLicense 0101276780 · taxonomy 207RX0202X
  • District of Columbia licenseLicense MD044015
  • Specialist, MarylandLicense D0064525 · taxonomy 174400000X
  • Pennsylvania licenseLicense MD437045

Medical oncologists near Dr. Lin

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Jianqing Lin billed Medicare for 1,061 services in 2024

CMS data shows 1,061 Medicare services from Dr. Lin across 6 procedure codes in 2024, for 342 Medicare patients. Medicare paid $74,557 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,061
Medicare patients342
Paid by Medicare$74,557
Procedure codes6

Dr. Lin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,0382024: 1,0612%

Dr. Lin compared with the Virginia median for medical oncologists, 2024

  • Dr. Lin
  • Virginia median
Medicare services
1,061vs 56687% above
Medicare patients
342vs 22254% above
Part D claims
970vs 3033.2 times

Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.

Dr. Lin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lin

Need commercial claims for Dr. Lin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lin and other medical oncologists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Jianqing Lin treated 342 Medicare patients in 2024, average age 75

CMS counts 342 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 67, with 48% women.

Medicare patients, 2024342
Average age75
Average risk score2.12
Also on Medicaid10%

Dr. Lin's Medicare patients by age, 2024

Dr. Lin's Medicare patients by sex, 2024

  • Women15746%
  • Men18554%

Chronic conditions among Dr. Lin's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis49%
  4. Cancer48%
  5. Diabetes37%
  6. Anxiety31%
  7. Ischemic heart disease30%
  8. Mood disorders30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women48%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Jianqing Lin wrote 1,242 Medicare Part D claims in 2024

In 2024, Dr. Lin wrote 1,242 Medicare Part D claims for 235 patients. 82% of them were for generic drugs. CMS names the drug for 970 of them, across 34 drugs with 11 or more claims each, at $2,000,266 in total drug cost. In 2023, CMS named 744 claims across 28 drugs.

Part D claims, 20241,242
Drugs named by CMS34
Total drug cost$2M
Part D patients235

Dr. Lin's Part D claims by kind of drug, 2024

  • Generic1,022 claims82%
  • Brand-name220 claims18%

Dr. Lin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lin's Part D claims, 2024

  • Opioids4%50 of 1,242 claims
  • Antibiotics4%54 of 1,242 claims
  • Antipsychotics, patients 65 and over1%14 of 1,242 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7442024: 97030%

Drugs named by CMS: 34 in 2024, 28 in 2023.

See all prescribing by Dr. Lin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Jianqing Lin takes part in Medicare

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Lin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Jianqing Lin has 34 publications on record

Dmand AI links 34 papers to Dr. Lin, published from 2010 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant and Antineoplastic Agents. Dr. Lin has published most often in Am J Clin Oncol. Dr. Lin's most frequent co-authors are Adam P. Dicker, MD, Robert B. Den, MD and Jean H. Hoffman-Censits, MD.

Papers34
Years published2010 to 2023

Dr. Lin's papers by year, 2011 to 2023

Topics Dr. Lin writes about most

  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Antineoplastic Agents
  • Molecular Targeted Therapy
  • Neoplasm Metastasis
  • Prostate-Specific Antigen
  • Receptors, Androgen
  • Androgen Antagonists

Dr. Lin's most frequent co-authors

Recent publications by Dr. Lin

See all 34 publications and co-authors

See who Dr. Lin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lin works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Jianqing Lin has worked on 10 clinical trials

Dmand AI links Dr. Lin to 10 clinical trials, 4 of them phase 1 studies. 7 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 5.

Clinical trials with Dr. Lin by phase

  1. 4Phase 1: 4 trials
  2. 1Phase 2: 1 trial
  3. 4Phase 3: 4 trials
  4. NonePhase 4: no trials

Conditions in Dr. Lin's trials

  • Prostatic Neoplasms
  • Prostatic Diseases
  • Carcinoma, Renal Cell
  • Lymphatic Metastasis
  • Pancreatic Neoplasms

Investigators on the most trials with Dr. Lin

Recent clinical trials with Dr. Lin

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Jianqing Lin received $15,400 in industry payments from 2016 to 2024

CMS Open Payments shows 76 general payments to Dr. Lin from 16 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,085.

General payments to Dr. Lin by program year, 2016 to 2024

General payments to Dr. Lin by kind, 2016 to 2024

$15.4Kin total
  • Speaker and faculty fees$8,70056%
  • Travel and lodging$3,23021%
  • Food and beverage$2,82218%
  • Education$6484%

Companies that paid Dr. Lin the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Lin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Jianqing Lin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Jianqing Lin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Jianqing Lin's NPI number?

Dr. Jianqing Lin's NPI number is 1285787267. It was assigned on January 21, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Jianqing Lin?

Dr. Jianqing Lin is a medical oncologist in Rockingham, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Jianqing Lin practice?

Dr. Lin practices at 2010 Health Campus Drive, Harrisonburg, VA 22801. Dr. Lin's primary practice is Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health. Dmand AI also links Dr. Lin to 1 hospital and 1 group practice or clinic.

What is Dr. Jianqing Lin's office phone number?

The practice phone on file for Dr. Lin is (540) 689-1000.

What is Dr. Jianqing Lin's medical license number?

Dr. Lin holds Virginia license 0101276780, one of the licenses on file in 4 states.

Which states has Dr. Jianqing Lin been licensed in?

Dmand AI has state licenses on file for Dr. Lin in Virginia, District of Columbia, Maryland and Pennsylvania.

Which hospitals is Dr. Jianqing Lin affiliated with?

Dr. Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia. Dr. Lin is also affiliated with University Medical Center. Dmand AI links Dr. Lin to 1 more hospital.

What medical group is Dr. Jianqing Lin part of?

Dr. Lin is linked to Sentara RMH Medical Group.

Does Dr. Jianqing Lin accept Medicare?

Yes. CMS data shows Dr. Lin billed Medicare for 1,061 services in 2024, and Dr. Lin accepts Medicare assignment.

How many Medicare patients does Dr. Jianqing Lin see?

CMS counts 342 Medicare patients who saw Dr. Lin in 2024, with an average age of 75.

Show 6 more questionsShow fewer questions

What services does Dr. Jianqing Lin bill to Medicare?

In 2024, Dr. Lin's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).

What drugs does Dr. Jianqing Lin prescribe most?

In 2024 Medicare Part D data, Dr. Lin's most prescribed drugs by claims were Anastrozole, Levothyroxine Sodium and Prochlorperazine Maleate.

Has Dr. Jianqing Lin received payments from drug or device companies?

CMS Open Payments shows $15,400 in general payments to Dr. Lin from 16 companies from 2016 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Jianqing Lin been practicing?

Dr. Lin graduated from medical school in 1986, 40 years ago.

Does Dr. Jianqing Lin do research?

Dmand AI links 34 publications to Dr. Lin, published from 2010 to 2023. Dr. Lin has worked on 10 clinical trials.

Who does Dr. Jianqing Lin publish with?

Dr. Lin's most frequent co-authors are Adam P. Dicker, MD (6 shared papers), Robert B. Den, MD (5 shared papers) and Jean H. Hoffman-Censits, MD (3 shared papers).

Selling to medical oncology practices?

See medical oncologists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)